Amaral LM - Search Results

1

Increased NOS coupling by the metabolite tetrahydrobiopterin (BH4) reduces preeclampsia/IUGR consequences.

Chatre L, Ducat A, Spradley FT, Palei AC, Chéreau C, Couderc B, Thomas KC, Wilson AR, Amaral LM, Gaillard I, Méhats C, Lagoutte I, Jacques S, Miralles F, Batteux F, Granger JP, Ricchetti M, Vaiman D. Chatre L, et al. Among authors: amaral lm. Redox Biol. 2022 Sep;55:102406. doi: 10.1016/j.redox.2022.102406. Epub 2022 Jul 30. Redox Biol. 2022. PMID: 35964341 Free PMC article.

2

Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity.

Sandrim VC, Palei AC, Sertório JT, Amaral LM, Cavalli RC, Tanus-Santos JE. Sandrim VC, et al. Among authors: amaral lm. Clin Biochem. 2011 Aug;44(12):1012-4. doi: 10.1016/j.clinbiochem.2011.05.026. Epub 2011 Jun 13. Clin Biochem. 2011. PMID: 21683071

3

Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy.

Palei AC, Sandrim VC, Amaral LM, Machado JS, Cavalli RC, Duarte G, Tanus-Santos JE. Palei AC, et al. Among authors: amaral lm. Exp Mol Pathol. 2012 Apr;92(2):217-21. doi: 10.1016/j.yexmp.2012.01.008. Epub 2012 Feb 1. Exp Mol Pathol. 2012. PMID: 22327101 Free article.

4

Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy.

Palei AC, Sandrim VC, Amaral LM, Machado JS, Cavalli RC, Lacchini R, Duarte G, Tanus-Santos JE. Palei AC, et al. Among authors: amaral lm. Basic Clin Pharmacol Toxicol. 2012 Oct;111(4):262-7. doi: 10.1111/j.1742-7843.2012.00905.x. Epub 2012 Jun 27. Basic Clin Pharmacol Toxicol. 2012. PMID: 22672240 Free article.

5

Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia.

Sertório JT, Lacchini R, Amaral LM, Palei AC, Cavalli RC, Sandrim VC, Duarte G, Tanus-Santos JE. Sertório JT, et al. Among authors: amaral lm. J Hum Hypertens. 2013 Jun;27(6):349-54. doi: 10.1038/jhh.2012.57. Epub 2012 Dec 6. J Hum Hypertens. 2013. PMID: 23223086

6

Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.

Luizon MR, Palei AC, Sandrim VC, Amaral LM, Machado JS, Lacchini R, Cavalli RC, Duarte G, Tanus-Santos JE. Luizon MR, et al. Among authors: amaral lm. Pharmacogenomics J. 2014 Dec;14(6):535-41. doi: 10.1038/tpj.2014.26. Epub 2014 Jun 24. Pharmacogenomics J. 2014. PMID: 24913092

7

Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.

Luizon MR, Belo VA, Palei AC, Amaral LM, Lacchini R, Sandrim VC, Duarte G, Cavalli RC, Tanus-Santos JE. Luizon MR, et al. Among authors: amaral lm. Hypertens Res. 2015 May;38(5):361-6. doi: 10.1038/hr.2015.15. Epub 2015 Feb 26. Hypertens Res. 2015. PMID: 25716650

8

Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.

Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli RC, Sandrim VC, Tanus-Santos JE. Luizon MR, et al. Among authors: amaral lm. Pharmacogenomics J. 2017 Oct;17(5):427-434. doi: 10.1038/tpj.2016.35. Epub 2016 May 10. Pharmacogenomics J. 2017. PMID: 27168100

9

Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes.

Amaral LM, Sandrim VC, Kutcher ME, Spradley FT, Cavalli RC, Tanus-Santos JE, Palei AC. Amaral LM, et al. Int J Mol Sci. 2021 Jan 8;22(2):564. doi: 10.3390/ijms22020564. Int J Mol Sci. 2021. PMID: 33429954 Free PMC article.

10

NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia.

Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli RC, Tanus-Santos JE, Luizon MR. Pereira DA, et al. Among authors: amaral lm. Pharmacogenomics. 2021 Jun;22(8):451-464. doi: 10.2217/pgs-2021-0006. Epub 2021 May 4. Pharmacogenomics. 2021. PMID: 33944612 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page